These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7522382)

  • 1. Hypervariable epitope constructs as a means of accounting for epitope variability.
    Anderson DE; Malley A; Benjamini E; Gardner MB; Torres JV
    Vaccine; 1994 Jun; 12(8):736-40. PubMed ID: 7522382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
    Meyer D; Anderson DE; Gardner MB; Torres JV
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
    Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE
    J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypervariable epitope construct: a synthetic immunogen that overcomes MHC restriction of antigen presentation.
    Meyer D; Torres JV
    Mol Immunol; 1999 Jul; 36(10):631-7. PubMed ID: 10509814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques.
    Torres JV; Anderson DE; Malley A; Banapour B; Axthelm MK; Benjamini E; Gardner MB
    J Med Primatol; 1993; 22(2-3):129-37. PubMed ID: 7692056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytotoxic and helper T cell responses by modified simian immunodeficiency virus hypervariable epitope constructs.
    Meyer D; Torres JV
    Viral Immunol; 1999; 12(2):117-29. PubMed ID: 10413358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation.
    Torres JV; Malley A; Banapour B; Anderson DE; Axthelm MK; Gardner MB; Benjamini E
    AIDS Res Hum Retroviruses; 1993 May; 9(5):423-30. PubMed ID: 7686386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission.
    Shafferman A; Lewis MG; McCutchan FE; Benveniste RE; Jahrling PB; Hickman RL; Lai CY; Burke DS; Eddy GA
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1483-7. PubMed ID: 1281660
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
    Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
    J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of broadly reactive continuous antigenic determinants of simian immunodeficiency virus glycoproteins.
    Miller MA; Murphey-Corb M; Montelaro RC
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1153-64. PubMed ID: 1380262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope.
    Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
    J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.
    Miller MD; Gould-Fogerite S; Shen L; Woods RM; Koenig S; Mannino RJ; Letvin NL
    J Exp Med; 1992 Dec; 176(6):1739-44. PubMed ID: 1460429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    Babas T; Le Grand R; Dormont D; Bahraoui E
    AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of humoral immunity to SIVenv following simultaneous inoculation of mice by three recombinant adenoviruses encoding SIVenv/poliovirus chimeras, Tat and Rev.
    Chenciner N; Randrianarison-Jewtoukoff V; Delpeyroux F; Hanania N; Pedroza Martins L; Stratford Perricaudet L; Perricaudet M; Wain-Hobson S
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):801-6. PubMed ID: 9171225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simian immunodeficiency virus DNA vaccine trial in macaques.
    Robinson HL; Lu S; Mustafa F; Johnson E; Santoro JC; Arthos J; Winsink J; Mullins JI; Montefiori D; Yasutomi Y
    Ann N Y Acad Sci; 1995 Nov; 772():209-11. PubMed ID: 8546394
    [No Abstract]   [Full Text] [Related]  

  • 20. SIV and FIV vaccine studies at UC Davis: 1991 update.
    Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.